Details for Patent: 7,198,801
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,198,801 protect, and when does it expire?
Patent 7,198,801 protects ELESTRIN and GELNIQUE 3% and is included in two NDAs.
This patent has fifty-five patent family members in twenty countries.
Summary for Patent: 7,198,801
Title: | Formulations for transdermal or transmucosal application |
Abstract: | The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent. The invention is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. |
Inventor(s): | Carrara; Dario Norberto R. (Oberwil, CH), Grenier; Arnaud (Steinbrunn le Haut, FR), Besse; Celine (Saint Louis, FR), Simes; Stephen M. (Long Grove, IL), Lehman; Leah M. (Green Oaks, IL) |
Assignee: | Antares Pharma IPL AG (Zug, CH) |
Application Number: | 10/798,161 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,198,801 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Delivery; |
Drugs Protected by US Patent 7,198,801
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | ELESTRIN | estradiol | GEL, METERED;TRANSDERMAL | 021813-001 | Dec 15, 2006 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Allergan | GELNIQUE 3% | oxybutynin | GEL, METERED;TRANSDERMAL | 202513-001 | Dec 7, 2011 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,198,801
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
PCT/EP00/07533 | Aug 03, 2000 |
International Family Members for US Patent 7,198,801
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 030312 | See Plans and Pricing | |||
Austria | 355854 | See Plans and Pricing | |||
Austria | 356636 | See Plans and Pricing | |||
Austria | 485837 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |